BT
NVO

Banque Transatlantique’s Novo Nordisk NVO Stock Holding History

Banque Transatlantique’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Buy
8,088
+106
+1% +$4.55K 0.01% 253
2026
Q1 		$284K Buy
7,982
+7,037
+745% +$333K 0.01% 233
2025
Q4 		$48.1K Sell
945
-1,410
-60% -$72.1K ﹤0.01% 163
2025
Q3 		$131K Sell
2,355
-3,399
-59% -$199K ﹤0.01% 135
2025
Q2 		$398K Buy
5,754
+2,924
+103% +$199K 0.01% 95
2025
Q1 		$195K Sell
2,830
-1,980
-41% -$164K 0.01% 116
2024
Q4 		$411K Buy
+4,810
New +$520K 0.01% 99

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Banque Transatlantique's NVO Position: Q2 2026 in Review

Banque Transatlantique increased its Novo Nordisk (NVO) stake by 1.3% in Q2 2026, buying an estimated $4.55K and bringing the position to 8,088 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #253.

Banque Transatlantique first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $411K in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Banque Transatlantique held 8,088 shares of Novo Nordisk worth $388K as of Q2 2026.
  • Banque Transatlantique bought 106 Novo Nordisk shares in Q2 2026, an estimated $4.55K.
  • Novo Nordisk made up 0.01% of Banque Transatlantique's portfolio in Q2 2026, its #253 holding.
  • Banque Transatlantique first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Novo Nordisk position peaked at $411K in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.